Objective: To assess the prognosis of individuals with gender identity disorder (GID) receiving hormonal therapy as a part of sex reassignment in terms of quality of life and other self-reported psychosocial outcomes.
Methods: We searched electronic databases, bibliography of included studies and expert files. All study designs were included with no language restrictions.